ライフサイエンスコーパス: is needed

1 ndard PELDOR measurement, and confirm that lambda < 1/(n-1) is needed to sufficiently suppress multispin effects (with n

2 proach but better understanding of this mechanism of action is needed.

3 ntation of standardized protocols for sampling and analysis is needed to improve the reproducibility and comparability of

4 ngitudinal research with a robust dietary intake assessment is needed to test this hypothesis.

5 osols (i.e., vapor plus particulate phases) of e-cigarettes is needed in order to better inform basic research as well as

6 dpoint result; further research into the role of complement is needed.

7 nderstanding of the current-day magnitude of each component is needed to create accurate projections of future relative s

8 of interventions targeting multiple steps in the continuum is needed to achieve the full beneficial impact of HIV treatm

9 Further validation in other countries is needed.

10 Customised service delivery is needed to ensure parity for different geographic and secur

11 about exposures in schools, childcare facilities, and homes is needed.

12 Studying the role of regional hypermetabolism is needed to better understand its interaction with the motor

13 effects of oxytocin on neural circuits in the hypothalamus is needed to establish the utility of targeting oxytocin sign

14 provide long-term protection against dengue virus infection is needed.

15 Reduction of biliary complications, especially ITBL, is needed to improve the outcomes for DCD grafts.

16 Shared decision making is needed to support decisions about breast reconstruction.

17 sight into how polycations disrupt and cross cell membranes is needed for understanding and controlling polycation-membra

18 nsplant cohorts, but use of more precise diagnostic methods is needed to better define epidemiology and underlying etiolo

19 nd sex because only a small amount of ovary sample (<50 mg) is needed for the approach established in the current work.

20 Moreover, our data indicate that PI(4)P is needed to anchor Arl8 (Arf-like GTPase 8) and its effector

21 ogeneous group of clinical subtypes, and further refinement is needed to improve treatment outcomes.

22 s, suggesting that additional, auxin-independent regulation is needed.

23 Research is needed to confirm possible interactions of arsenic metabol

24 Research is needed to develop safe and effective treatments, a prevent

25 Research is needed to inform firm recommendations on how to protect th

26 Further research is needed on procedural and long-term clinical outcomes.

27 Further research is needed to assess longer-term efficacy and adverse effects.

28 Further research is needed to investigate the association between these struct

29 Further research is needed to understand how these noncardiac complications ma

30 More research is needed to inform our knowledge of the role of insurance an

31 More research is needed to understand the effectiveness of screening and tr

32 cal and agronomic factors underlying neonicotinoid residues is needed to inform evidence-based policy.

33 at of organizing, visualizing, and interpreting the results is needed.

34 aryotic genomes; however, at present additional scaffolding is needed to achieve chromosome-level assemblies.

35 Validation of this novel predictive score is needed to confirm clinical utility.

36 ng the forms and quantities of mitochondrial calcium stores is needed.

37 Further study is needed to assess safety and long-term clinical outcome.

38 Although further study is needed, this report shows promising results and raises imp

39 clinical diagnosis difficult; therefore, laboratory testing is needed to confirm the diagnosis.

40 lysomes to non-translating mRNPs, and recapping is all that is needed for their return to the translating pool.

41 Biosensors can deliver the rapid bacterial detection that is needed in many fields including food safety, clinical diag

42 to patients with type 2 diabetes when pharmacologic therapy is needed to improve glycemic control.

43 Innovation in education and training is needed to better prepare future nephrologists for the grow

44 A randomized trial is needed.

45 urrence rate is higher, and vigilant and extended follow-up is needed because retinal vascularization is usually incomple

46 Longer term follow-up is needed to assess the durability of quality-of-life improve

47 ing of living cells as well as their microenvironment which is needed to assess the development of diseases.

48 Further work is needed to determine the implications of increased thalamic

49 More work is needed to optimize its dosing to minimize adverse events,

50 between burying beetles and P. carabi mites, but more work is needed to understand the functional significance and fitne